Michelle Lynn Hall

Company: Lilly and Company

Job title: Associate Vice President

Seminars:

Nose-to-brain Delivery of Oligonucleotides 4:30 pm

Showcasing the delivery to the brain remains an incredibly challenging but holds immense promise for nucleic acids Evaluating the state-of-the-art for oligonucleotide therapies to the CNS is highly invasive direct delivery (e.g.., intrathecal injection directly into the cerebrospinal fluid) Describing work using formulations and a localization device to deliver oligonucleotides as in a minimally-invasive way…Read more

day: Focus Day